PERSISTENCE AND OTHER TREATMENT PATTERNS AMONG BIO-EXPERIENCED PATIENTS WITH CROHN'S DISEASE INITIATED ON USTEKINUMAB OR ADALIMUMAB

被引：0
|
作者：
Zhdanava, Maryia
Zhao, Ruizhi
Manceur, Ameur M.
Ding, Zhijie
Kachroo, Sumesh
Peddle, Mark
Lefebvre, Patrick
Pilon, Dominic
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1568
引用
收藏
页码：S417 / S418
页数：2
相关论文
共 50 条
  • [21] Clinical, Endoscopic, and Radiological Effectiveness of Ustekinumab in Bio-naive Versus Bio-experienced Patients With Crohn's Disease: Real-world Experience From a Large Canadian Center
    Sedano, Rocio
    Guizzetti, Leonardo
    McDonald, Cassandra
    Beaton, Melanie
    Chande, Nilesh
    Gregor, Jamie
    Sey, Michael
    Wilson, Aze
    Jairath, Vipul
    [J]. INFLAMMATORY BOWEL DISEASES, 2023, 29 (06) : 866 - 874
  • [22] TREATMENT PERSISTENCE AND MAINTENANCE DOSING FOR USTEKINUMAB AND ADALIMUMAB AMONG PATIENTS WITH CROHN'S DISEASE WITH TWO-YEARS FOLLOW-UP IN THE SYMPHONY HEALTH DATABASE
    Muser, Erik
    Obando, Camilo
    Ding, Zhijie
    Slaton, Terra
    Kozma, Chris
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S959 - S959
  • [23] Comparison of the efficacy of adalimumab and ustekinumab for prevention of intestinal fibrosis in bio-naive Crohn's Disease patients
    Biscanin, A.
    Tomasic, V.
    Babic, F.
    Cacic, P.
    Kordej, D. Ogresta
    Hrabar, D.
    Kralj, D.
    Dorosulic, Z.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 695 - 695
  • [24] USTEKINUMAB VERSUS INFLIXIMAB AND ADALIMUMAB IN THE REALWORLD PERSISTENCE IN CROHN'S DISEASE - A META-ANALYSIS
    Yiu, Tsz Hong
    Ko, Yanna
    Pudipeddi, Aviv
    Chetwood, John D.
    Leong, Rupert
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S657 - S657
  • [25] EVALUATION OF HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG BIO-EXPERIENCED CROHN'S DISEASE PATIENTS TREATED WITH BIOLOGICS WITH TWO YEARS OF FOLLOW-UP
    Cyhaniuk, A.
    Zhao, R.
    Ding, Z.
    Gupta, P.
    Kachroo, S.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S429 - S429
  • [26] Real-world persistence of ustekinumab vs infliximab and adalimumab in patients with Crohn's disease: A meta-analysis
    Yiu, T. H.
    Ko, Y.
    Pudipeddi, A.
    Chetwood, J.
    Leong, R.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 195 - 195
  • [27] Real-World Long-Term Persistence and Surgical Procedure-Free Period Among Bio-naive Patients with Crohn's Disease and Fistula Initiated on Ustekinumab
    Zhdanava, Maryia
    Kachroo, Sumesh
    Boonmak, Porpong
    Burbage, Sabree
    Shah, Aditi
    Lefebvre, Patrick
    Kerner, Caroline
    Pilon, Dominic
    [J]. ADVANCES IN THERAPY, 2024, 41 (10) : 3922 - 3933
  • [28] Long-term effectiveness and safety of ustekinumab in bio-naive and bio-experienced anti-tumor necrosis factor patients with Crohn's disease: a real-world multicenter Brazilian study
    Parra, Rogerio Serafim
    Fonseca Chebli, Julio Maria
    Freitas Queiroz, Natalia Sousa
    Mourao Cintra Damiao, Aderson Omar
    Cardoso de Azevedo, Matheus Freitas
    Chebli, Liliana Andrade
    Bertges, Erika Ruback
    Tiburcio Alves Junior, Antonio Jose
    Ambrogini Junior, Orlando
    Pona Schiavetti da Silva, Bianca Loyo
    Lubini, Marcio
    Bafutto, Mauro
    Flores, Cristina
    Vilela, Eduardo Garcia
    Boratto, Sandra Felice
    Tricarico Gasparetti Junior, Newton Luiz
    Steinwurz, Flavio
    Carvalho, Nayara Salgado
    Feres, Omar
    Ribeiro da Rocha, Jose Joaquim
    [J]. BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [29] Comparative Treatment Patterns Among Psoriasis Patients Using Adalimumab, Etanercept, or Ustekinumab
    Carter, Chureen
    Wilson, Kathleen L.
    Smith, David
    Lee, Seina
    [J]. AMERICAN JOURNAL OF PHARMACY BENEFITS, 2016, 8 (05) : 191 - 198
  • [30] Treatment patterns, persistence with therapy, and outcomes of ustekinumab in Crohn's disease: Real-world data analysis
    Banon, Tamar
    Weil, Clara
    Borsi, Andras
    Chodick, Gabriel
    Shakked, Zehavi
    Ben-David, Nava Barit
    [J]. JGH OPEN, 2022, 6 (02): : 120 - 125
12345